A Dose Titration Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome With a Double-Blind, Placebo-Controlled, Randomized Withdrawal Extension
Latest Information Update: 26 Sep 2019
At a glance
- Drugs Diazoxide (Primary)
- Indications Prader-Willi syndrome
- Focus Therapeutic Use
- Sponsors Essentialis
- 24 Sep 2019 According to a Soleno Therapeutics media release, results of this study have been published for the first time in a peer-reviewed journal PLOS One.
- 15 Nov 2018 Results published in the Media Release
- 15 Nov 2018 According to a Soleno Therapeutics media release, data were presented at the Obesity Society Meeting 2018.